AbbVie Ventures
| Federal/State Opportunity Number | Not Applicable |
| Funding Opportunity Purpose | AbbVie Ventures: Investing since 2009, the focus is exclusively on novel, transformational therapeutics at discovery and pre-clinical stages. Aligning with AbbVie’s strategic focus, the investments address critical needs in oncology, immunology, neuroscience, eye care, and aesthetics. Offering partners access to AbbVie’s vast internal network of experts in all phases of drug development, from drug discovery through successful commercialization. |
| Type of Funding Opportunity | Private |
| Florida Resident Specific Opportunity | No |
| Funding Mechanism | Equity Financing |
| Organization | AbbVie |
| Focus Area | All Innovation |
| Funding Size | Not Specified |
| Funding Post Date | Not Specified |
| Funding Closing Date | Rolling Basis - Indefinitely |
| Funding Timelines | Not Specified |
| Funding Opportunity Cycle | Recurring |
| Eligible Recipients | Entrepreneurs |
| Non-For-Profit Funding Only | No |
| Small Business Funding Only | No |
| Early Stage Funding Only | No |
| Minority Ownership Required | No |
| US Ownership Required | Not Specified |
| Federal Cost Share Requirements | No |
| Contact Information | Email: abbvieventures@abbvie.com |
| Website Link | https://www.abbvie.com/science/partner-with-us.html |
| Additional Eligibility Criteria Notes | Eligibility criteria includes transformational scientific opportunities aligned with AbbVie Ventures’ core R&D interests (Immunology, Oncology, Neuroscience, Eye Care, Aesthetics, Virology, Cystic Fibrosis, Women’s Health, & Platform and Technologies) |
| Additional Information Application Process | Not Identifiable |
| Important Reporting Requirements (If Specified) | Not Specified |
| Miscellaneous Notes | Not Identifiable |